FDA Urges Lower Target for ESA Use; Market Could Drop By More Than Half.
CMS Launches National Coverage Analysis, Citing FDA’s Black Box Warning on ESAs.
FDA Purges Quality of Life Claims from Oncology Label for ESAs.
Amgen Says It Can Demonstrate Safety of Existing Hg Target.
If You Were On ODAC: Experts Suggest Questions For May 10 Advisory Meeting.
Trending Stories
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - What are The CheckPoints movin’ and groovin’ to this summer?
Join the journal club with the best bops: We asked SITC’s 13-piece band of medical musicians for the top papers and songs of the summer - Raja Flores says oncology is loose with staging jargon, and now “it’s confusing my patients.”
- From the desk of Kimryn Rathmell: What to read before these beautiful days slip away
My summer reading challenged me to see people, purpose, and complexity in a new way









